Clinical Conversations: Fetal Alcohol Syndrome – A Practical Approach for GPs | Part two

A/Prof Carmela Pestell

writer

A/Prof Carmela Pestell

Clinical Psychologist/Neuropsychologist; Co-Director, Robin Winkler Clinic, UWA

Claim CPD for this activity

Educational Activities (EA)

0 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA
0 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0 minutes

These are activities that require reflection on feedback about your work.

MO
0 minutes

These are activities that use your work data to ensure quality results.

 

Fetal alcohol spectrum disorder (FASD) is an underdiagnosed condition that should be suspected in patients with neurodevelopmental delay, learning difficulties and in some cases, specific facial features.

Those who have been in the justice system are also at high risk, based on research by A/Prof. Carmela Pestell and her colleagues. She has been involved with FASD for decades and wants to increase awareness of this condition. Early diagnosis and intervention gives the best chance of a productive life for the person with FASD.

This is part two of this series. Read Part 1 >>

Practice points

• Any clinician that is taking a developmental history should always ask whether or not there was alcohol exposure during pregnancy.
• Children are quite individual with FASD and are at risk of a whole host of different secondary long-term outcomes. They have a lower life expectancy, they are more likely to develop substance issues themselves, they are more likely to come into contact with the justice system or develop severe mental health challenges.
• It is a myth that all children with FASD will have an intellectual difficulty; two thirds may have average to high average intelligence, but they have particular struggles in certain areas.
• An accurate diagnosis requires a multidisciplinary team approach. It is very important to tease out the child’s strengths and weaknesses and determine their unique cognitive profiles. If we know these, then we can then help tailor appropriate treatment intervention. Neuropsychological input can be particularly useful for these cases.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Samantha Hocking

A/Prof Samantha Hocking

Tirzepatide Compared to Semaglutide for Treatment of Obesity – Latest Evidence

A/Prof Gino Pecoraro OAM

A/Prof Gino Pecoraro OAM

Genitourinary Syndrome of Menopause – Mythbusting for GPs

Prof Sonia Grover

Prof Sonia Grover

Dysmenorrhoea in Teens

Prof Paul Griffin

Prof Paul Griffin

Winter Virus Preparations

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

A/Prof Carmela Pestell

writer

A/Prof Carmela Pestell

Clinical Psychologist/Neuropsychologist; Co-Director, Robin Winkler Clinic, UWA

Test your knowledge

Recent articles

Latest GP poll

"I am concerned about disrupted continuity of care for patients that use 1800Medicare"

Strongly agree

0%

Slightly agree

0%

Slightly disagree

0%

Strongly disagree

0%

Recent podcasts

Listen to expert interviews.
Click to open in a new tab

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Menopause and MHT

Multiple sclerosis vs antibody disease

Using SGLT2 to reduce cardiovascular death in T2D

Peripheral arterial disease